miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction]

MLA

Wei Li, et al. “MiR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction].” Cancer Management and Research, vol. 12, Dec. 2020, pp. 12581–82. EBSCOhost, https://doi.org/10.2147/cmar.s295016.

APA

Wei Li, Wang Yongfeng, Jinchun Xing, Kaiyan Zhang, Tao Wang, Zhenghua Wan, Peide Bai, Xuegang Wang, Yujuan Xiao, Zhun Wu, Wen Xiao, & Bin Chen. (2020). miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction]. Cancer Management and Research, 12, 12581–12582. https://doi.org/10.2147/cmar.s295016

Chicago

Wei Li, Wang Yongfeng, Jinchun Xing, Kaiyan Zhang, Tao Wang, Zhenghua Wan, Peide Bai, et al. 2020. “MiR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction].” Cancer Management and Research 12 (December): 12581–82. doi:10.2147/cmar.s295016.